MichaelKnableDO

PubMed

• 3 citations
  Assessment of the 2019 national institute of mental health grant portfolio for bipolar disorder research.
  Michael B. Knable, E. Fuller Torrey
  Journal of Affective Disorders. 2022-01-01
• 6 citations
  Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example.
  E. Fuller Torrey, Michael B. Knable, A. John Rush, Wendy W. Simmons, John D. Snook
  Plos One. 2020-11-19
• 1 citations
  Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial.
  Deborah Dauphinais, Michael Knable, Joshua Rosenthal, Mark Polanski, Norman Rosenthal
  Psychopharmacology Bulletin. 2011-05-15

Journal Articles

• The availability and effectiveness of residential treatment for persistent mental illness  
  Knable MB, Cantrell C, Vander Meer, Levine E, Psychiatric Annals, 1/1/2015
• William Whitney Godding and the concepts of asylum and therapeutic community  
  Knable MB, Psychiatric Annals, 1/1/2015
• Review of Karasu TB: Gotham Chronicles: The Culture of Sociopathy  
  Knable MB, Psychiatry, Interpersonal and Biological Processes, 1/1/2014
• Zonisamide for bipolar depression: a randomized, double-blind, placebo-controlled, adjunctive trial  
  Dauphinais D, Knable M, Rosenthal J, Polanski M, Rosenthal N, Psychopharmacology Bulletin, 1/1/2011
• Zonisamide for bipolar disorder, mania and mixed states: a randomized, double-blind, placebocontrolled, adjunctive trial  
  Dauphinais D, Knable M, Rosenthal J, Polanski M, Rosenthal N, Psychopharmacology Bulletin, 1/1/2011
• A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia  
  Mu Q, Johnson K, Morgan PS, Gernesko EL, Molnar CE, Anderson B, Nahas Z, Kozel FA, Kose S, Knable M, Fernandes P, Nichols DE, Mailman RB, George MS, Schizophrenia Research, 1/1/2007
• A single 20mg dose of dihdrexidine (DAR-0100), a full dopamine D1 agonist, is safe and well-tolerated in patients with schizophrenia  
  George MS, Molnar CE, Grenesko EL, Anderson B, Mu Q, Johnson K, Nahas Z, Knable MB, Fernandes P, Juncos J, Huang X, Nichols D, Mailman RB, Schizophrenia Research, 1/1/2007
• Meta-Analysis of 12 Genomic Studies in Bipolar Disorder  
  Elashoff M, Higgs BW, Yolken RH, Knable MB, Weis S, Webster MJ, Barci BM, Torrey EF, Journal of Molecular Neuroscience, 1/1/2007
• Deficient expression of proteosome, ubiquitin, and mitochondrial genes in hippocampal neurons of multiple schizophrenic patient groups  
  Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, Knable MB, Brockman JA, Biological Psychiatry, 1/1/2005
• Neurochemical markers for schizophrenia, bipolar disorder and major depression in post-mortem brains  
  Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB, Biological Psychiatry, 1/1/2005
• Molecular abnormalities of the hippocampus in severe mental illness: post-mortem findings from the Stanley Neuropathology Consortium  
  Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF, Molecular Psychiatry, 1/1/2004
• Secretin for refractory schizophrenia  
  Sheitman BB, Knable MB, Jarskog LF, Chakos M, Boyce LH, Early J, Lieberman JA, Schizophrenia Research, 1/1/2004
• Dr Fenton and colleagues reply  
  Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable MB, American Journal of Psychiatry, 1/1/2003
• In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia  
  Raedler TJ, Knable MB, Jones DW, Urbina RA, Gorey JG, Lee KS, Egan MF, Coppola R, Weinberger DR, American Journal of Psychiatry, 1/1/2003
• Abnormalities of the cingulate gyrus in bipolar disorder and other severe psychiatric illness: Post-mortem findings from the Stanley Foundation Neuropathology Consorti...  
  Knable MB, Barci BM, Bartko JJ, Webster MJ, Torrey EF, Clinical Neuroscience Research, 1/1/2002
• Molecular abnormalities in the major psychiatric illnesses: classification and regression tree (CART) analysis of post-mortem prefrontal markers  
  Knable MB, Barci BM, Bartko JJ, Webster MJ, Torrey EF, Molecular Psychiatry, 1/1/2002
• Test-retest stability of the repeatable battery for the assessment of neuropsychological status in schizophrenia  
  Wilk CM, Gold JM, Bartko JJ, Dickerson F, Boronow J, Fenton WS, Knable MB, Randolph C, American Journal of Psychiatry, 1/1/2002
• Relationship between cortisol and serotonin metabolites and transporters in alcoholism  
  Heinz A, Jones DW, Bissette G, Hommer D, Ragan P, Knable M, Wellek S, Linnoila M, Weinberger DR, Pharmacopsychiatry, 1/1/2002
• Preliminary experience with an Ampakine (CX-516) as a single agent for the treatment of schizophrenia: a case series  
  Marenco S, Egan MF, Goldberg T, Knable MB, McClure R, Winterer G, Weinberger DR, Schizophrenia Research, 1/1/2002
• A controlled trial of hydroxychloroquine in schizophrenia  
  Desta M, Tadesse A, Gebre N, Barci BM, Torrey EF, Knable MB, Journal of Clinical Psychopharmacology, 1/1/2002
• Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders  
  Webster MJ, Knable MB, O'Grady J, Orthmann J, Shannon-Weickert C, Molecular Psychiatry, 1/1/2002
• Commentary on: A double-blind, placebo-controlled trial of extract of Gingko biloba added to haloperidol in treatment-resistant patients with schizophrenia (Zhang et a...  
  Knable MB, Evidence-Based Mental Health, 1/1/2002
• Foreword  
  Knable MB, Webster MJ, Brain Research Bulletin, 1/1/2001
• Resolution of bulimia nervosa with topiramate therapy in a patient with epilepsy  
  Knable MB, American Journal of Psychiatry, 1/1/2001
• Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar d...  
  Webster MJ, Knable MB, Johnston-Wilson N, Inagaki M, Nagata K, Yolken RH, Brain, Behavior, and Immunity, 1/1/2001
• Join now to see all

Books/Book Chapters

• Conn's Current Therapy 
  Chapter: Schizophrenia 
  Page 1169 - 1171Knable MBEditors: Rakel RE, Bope ET.Saunders, Philadelphia2004
• The Post-Mortem Brain in Psychiatric Research 
  Chapter: Summary of prefrontal molecular abnormalities in the Stanley Foundation Neuropathology Consortium 
  Page 105 - 137Knable MB, Barci BM, Webster MJ, Torrey EFEditors: Agam G, Everall I, Belmaker RH.Kluwer Academic Publishers, Boston2002
• Surviving Manic-Depressive Illness: A Manual for Families, Consumers, and Providers 
  Torrey EF, Knable MBBasic Books, New York2002
• Psychiatry 
  Chapter: Pathophysiological basis of psychiatric disorders: focus on mood disorders and schizophrenia 
  Page 258 - 311Nemeroff CB, Musselman DL, Nathan KI, Schatzberg AF, Knable MB, Kleinman JE, Weinberger DR, Kilts CD, Weiss JMEditors: Tasman A, Kay J, Lieberman JA.Saunders, Philadelphia1997
• American Psychiatric Press Textbook of Psychopharmacology 
  Chapter: Neurobiology of schizophrenia 
  Page 479 - 499Knable MB, Kleinman JE, Weinberger DREditors: Schatzberg AF and Nemeroff CB.American Psychiatric Press, Washington, D.C.1995
• Join now to see all

Other

• Clozapine for Treating Schizophrenia. A Comparison of the States 
  Torrey EF, Knable MB, Quanbeck C, Davis JM, Treatment Advocacy Center
  http://tacreports.org/storage/documents/clozapine-for-treating-schizophrenia.pdf
  1/1/2015
• Missions impossible: The ongoing failure of NIMH to support sufficient research on severe mental disorders. 
  Torrey EF, Gottesman IG, Davis JM, Knable MB, Zdanowicz MT, Treatment Advocacy Center
  www.psychlaws.org
  Arlington, VA - 1/1/2000
• A mission forgotten: The failure of the National Institute of Mental Health to do sufficient research on severe mental illnesses 
  Torrey EF, Knable MB, Davis JM, Gottesman II, Flynn LM, National Alliance of the Mentally Ill
  www.nami.org
  Arlington, VA - 1/1/1999